Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis

Cancer and Metastasis Reviews

Volumn 32, Issue 3-4, 2013, Pages 363-376

  Thompson, Laura L ^a,b   Guppy, Brent J ^a,b   Sawchuk, Laryssa ^a,b   Davie, James R ^a,b,c   McManus, Kirk J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c John Buhler Research Centre   (Canada)

Author keywords

Cancer; Epigenetics; Genome instability; Histones; Methylation; Phosphorylation; Post translational modifications; Ubiquitination

Indexed keywords

HISTONE; HISTONE H2B; HISTONE H3; HISTONE H4;

ARTICLE; CANCER GENETICS; CARCINOGENESIS; CHROMATIN STRUCTURE; ENZYME ACTIVITY; EPIGENETICS; GENOMIC INSTABILITY; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, IMMEDIATE-EARLY; GENOMIC INSTABILITY; HISTONE DEMETHYLASES; HISTONES; HUMANS; INTERPHASE; METHYLATION; MITOSIS; NEOPLASMS; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTOME; UBIQUITINATION;

EID: 84890309922     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-013-9434-8     Document Type: Article

References (123)

1. Luger, K., et al. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature, 389(6648), 251-260.
2. Cohen, I., et al. (2011). Histone modifiers in cancer: friends or foes? Genes & Cancer, 2(6), 631-647.
3. Martin, C., & Zhang, Y. (2007). Mechanisms of epigenetic inheritance. Current Opinion in Cell Biology, 19(3), 266-272.
4. Margueron, R., Trojer, P., & Reinberg, D. (2005). The key to development: interpreting the histone code? Current Opinion in Genetics & Development, 15(2), 163-176.
5. Horn, P. J., et al. (2002). Phosphorylation of linker histones regulates ATP-dependent chromatin remodeling enzymes. Nature Structural Biology, 9(4), 263-267.
6. Williamson, W. D., & Pinto, I. (2012). Histones and genome integrity. Frontiers in Bioscience: A Journal and Virtual Library, 17, 984-995.
7. Ruthenburg, A. J., Allis, C. D., & Wysocka, J. (2007). Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Molecular Cell, 25(1), 15-30.
8. Kouzarides, T. (2007) SnapShot: histone-modifying enzymes. Cell, 131(4), 822.
9. Issa, J. P. (2004). CpG island methylator phenotype in cancer. Nature Reviews. Cancer, 4(12), 988-993.
10. Kerzendorfer, C., & O'Driscoll, M. (2009). Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency. DNA Repair, 8(9), 1139-1152.
11. Geigl, J. B., et al. (2008). Defining 'chromosomal instability'. Trends in Genetics: TIG, 24(2), 64-69.
12. Schroeder, T. M. (1982). Genetically-determined chromosome instability syndromes. Cytogenetics and Cell Genetics, 33(1-2), 119-132.
13. Huang, C. C., Banerjee, A., & Hou, Y. (1975). Chromosomal instability in cell lines derived from patients with xeroderma pigmentosum. Proceedings of the Society for Experimental Biology and Medicine, 148(4), 1244-1248.
14. Chrzanowska, K. H., et al. (2012). Nijmegen breakage syndrome (NBS). Orphanet Journal of Rare Diseases, 7, 13.
15. Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature, 396(6712), 643-649.
16. Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010). Genomic instability - an evolving hallmark of cancer. Nature Reviews. Molecular Cell Biology, 11(3), 220-228.
17. Drobic, B., et al. (2010). Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Research, 38(10), 3196-3208.
18. Prigent, C., & Dimitrov, S. (2003). Phosphorylation of serine 10 in histone H3, what for? Journal of Cell Science, 116(Pt 18), 3677-3685.
19. Goto, H., et al. (2002). Aurora-B phosphorylates histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes to Cells: Devoted to Molecular & Cellular Mechanisms, 7(1), 11-17.
20. Mahadevan, L. C., Willis, A. C., & Barratt, M. J. (1991). Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell, 65(5), 775-783.
21. Soloaga, A., et al. (2003). MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. The EMBO Journal, 22(11), 2788-2797.
22. Lee, Y. J., & Shukla, S. D. (2007). Histone H3 phosphorylation at serine 10 and serine 28 is mediated by p38 MAPK in rat hepatocytes exposed to ethanol and acetaldehyde. European Journal of Pharmacology, 573(1-3), 29-38.
23. Delcuve, G. P., Rastegar, M., & Davie, J. R. (2009). Epigenetic control. Journal of Cellular Physiology, 219(2), 243-250.
24. Caivano, M., & Cohen, P. (2000). Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. Journal of Immunology, 164(6), 3018-3025.
25. Davie, J. R. (2003). MSK1 and MSK2 mediate mitogen- and stress-induced phosphorylation of histone H3: a controversy resolved. Science's STKE: Signal Transduction Knowledge Environment, 2003(195), PE33.
26. Strelkov, I. S., & Davie, J. R. (2002). Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts. Cancer Research, 62(1), 75-78.
27. Macdonald, N., et al. (2005). Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Molecular Cell, 20(2), 199-211.
28. Winter, S., Fischle, W., & Seiser, C. (2008). Modulation of 14-3-3 interaction with phosphorylated histone H3 by combinatorial modification patterns. Cell Cycle, 7(10), 1336-1342.
29. Dunn, K. L., & Davie, J. R. (2005). Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28. Oncogene, 24(21), 3492-3502.
30. Dyson, M. H., et al. (2005). MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. Journal of Cell Science, 118(Pt 10), 2247-2259.
31. Dunn, K. L., et al. (2009). Increased genomic instability and altered chromosomal protein phosphorylation timing in HRAS-transformed mouse fibroblasts. Genes, Chromosomes & Cancer, 48(5), 397-409.
32. Lim, J. H., et al. (2004). Chromosomal protein HMGN1 modulates histone H3 phosphorylation. Molecular Cell, 15(4), 573-584.
33. Perez-Cadahia, B., Drobic, B., & Davie, J. R. (2009). H3 phosphorylation: dual role in mitosis and interphase. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire, 87(5), 695-709.
34. Shaulian, E., & Karin, M. (2002). AP-1 as a regulator of cell life and death. Nature Cell Biology, 4(5), E131-E136.
35. Jochum, W., Passegue, E., & Wagner, E. F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene, 20(19), 2401-2412.
36. Wagner, E. F. (2002). Functions of AP1 (Fos/Jun) in bone development. Annals of the Rheumatic Diseases, 61(Suppl 2), ii40-ii42.
37. Grigoriadis, A. E., et al. (1993). Osteoblasts are target cells for transformation in c-fos transgenic mice. The Journal of Cell Biology, 122(3), 685-701.
38. Ruther, U., Wagner, E. F., & Muller, R. (1985). Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. The EMBO Journal, 4(7), 1775-1781.
39. Wang, Z. Q., et al. (1995). c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Research, 55(24), 6244-6251.
40. van den Berg, S., et al. (1993). Overexpression of c-fos increases recombination frequency in human osteosarcoma cells. Carcinogenesis, 14(5), 925-928.
41. Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997). Genetic instability in colorectal cancers. Nature, 386(6625), 623-627.
42. Drobic, B., Espino, P. S., & Davie, J. R. (2004). Mitogen- and stress-activated protein kinase 1 activity and histone h3 phosphorylation in oncogene-transformed mouse fibroblasts. Cancer Research, 64(24), 9076-9079.
43. Forbes, S. A., et al. (2011). COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Research, 39(Database issue), D945-D950.
44. Forbes, S. A., et al. (2010). COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Research, 38(Database issue), D652-D657.
45. Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.
46. Schiller, M., et al. (2006). Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes. Oncogene, 25(32), 4449-4457.
47. Chang, S., et al. (2011). Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model. Cancer Investigation, 29(3), 240-245.
48. Kim, H. G., et al. (2008). Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Research, 68(7), 2538-2547.
49. Perez-Cadahia, B., et al. (2011). Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts. The Journal of Biological Chemistry, 286(1), 42-49.
50. Hendzel, M. J., et al. (1997). Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma, 106(6), 348-360.
51. McManus, K. J., & Hendzel, M. J. (2006). The relationship between histone H3 phosphorylation and acetylation throughout the mammalian cell cycle. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire, 84(4), 640-657.
52. Goto, H., et al. (1999). Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. The Journal of Biological Chemistry, 274(36), 25543-25549.
53. Crosio, C., et al. (2002). Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Molecular and Cellular Biology, 22(3), 874-885.
54. Kallio, M. J., et al. (2002). Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Current Biology: CB, 12(11), 900-905.
55. Murata-Hori, M., Tatsuka, M., & Wang, Y. L. (2002). Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis. Molecular Biology of the Cell, 13(4), 1099-1108.
56. Van Hooser, A., et al. (1998). Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. Journal of Cell Science, 111(Pt 23), 3497-3506.
57. Katayama, H., et al. (2004). Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics, 36(1), 55-62.
58. Ota, T., et al. (2002). Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Research, 62(18), 5168-5177.
59. Tuncel, H., et al. (2012). Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer. Oncology Letters, 3(5), 1109-1114.
60. Qi, G., et al. (2007). Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Archiv: An International Journal of Pathology, 450(3), 297-302.
61. Lee, E. C., et al. (2006). Targeting Aurora kinases for the treatment of prostate cancer. Cancer Research, 66(10), 4996-5002.
62. Kurai, M., et al. (2005). Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma. Human Pathology, 36(12), 1281-1288.
63. Sorrentino, R., et al. (2005). Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. The Journal of Clinical Endocrinology and Metabolism, 90(2), 928-935.
64. Harrington, E. A., et al. (2004). VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature Medicine, 10(3), 262-267.
65. Hsu, J. Y., et al. (2000). Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell, 102(3), 279-291.
66. de Carvalho, C. E., et al. (2008). LAB-1 antagonizes the Aurora B kinase in C. elegans. Genes & Development, 22(20), 2869-2885.
67. Ladha, J., et al. (2010). Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes. Cancer Research, 70(16), 6437-6447.
68. Rea, S., et al. (2000). Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature, 406(6796), 593-599.
69. Lachner, M., O'Sullivan, R. J., & Jenuwein, T. (2003). An epigenetic road map for histone lysine methylation. Journal of Cell Science, 116(Pt 11), 2117-2124.
70. He, Y., et al. (2012). Targeting protein lysine methylation and demethylation in cancers. Acta biochimica et biophysica Sinica, 44(1), 70-79.
71. Steward, M. M., et al. (2006). Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nature Structural & Molecular Biology, 13(9), 852-854.
72. Santos-Rosa, H., et al. (2002). Active genes are tri-methylated at K4 of histone H3. Nature, 419(6905), 407-411.
73. Wang, H., et al. (2001). Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Molecular Cell, 8(6), 1207-1217.
74. Beck, D. B., et al. (2012). PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. Genes & Development, 26(4), 325-337.
75. Rice, J. C., et al. (2002). Mitotic-specific methylation of histone H4 Lys 20 follows increased PR-Set7 expression and its localization to mitotic chromosomes. Genes & Development, 16(17), 2225-2230.
76. Nishioka, K., et al. (2002). PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Molecular Cell, 9(6), 1201-1213.
77. Xiao, B., et al. (2005). Specificity and mechanism of the histone methyltransferase Pr-Set7. Genes & Development, 19(12), 1444-1454.
78. Couture, J. F., et al. (2005). Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase. Genes & Development, 19(12), 1455-1465.
79. Houston, S. I., et al. (2008). Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. The Journal of Biological Chemistry, 283(28), 19478-19488.
80. Sims, J. K., et al. (2006). A trans-tail histone code defined by monomethylated H4 Lys-20 and H3 Lys-9 demarcates distinct regions of silent chromatin. The Journal of Biological Chemistry, 281(18), 12760-12766.
81. Biron, V. L., et al. (2004). Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development. Developmental Biology, 276(2), 337-351.
82. Lu, X., et al. (2008). The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure. Nature Structural & Molecular Biology, 15(10), 1122-1124.
83. Davey, C. A., et al. (2002). Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. Journal of Molecular Biology, 319(5), 1097-1113.
84. Dorigo, B., et al. (2003). Chromatin fiber folding: requirement for the histone H4 N-terminal tail. Journal of Molecular Biology, 327(1), 85-96.
85. Liu, W., et al. (2010). PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature, 466(7305), 508-512.
86. Oda, H., et al. (2009). Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Molecular and Cellular Biology, 29(8), 2278-2295.
87. Yang, F., et al. (2012). SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities. The EMBO Journal, 31(1), 110-123.
88. Kalakonda, N., et al. (2008). Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene, 27(31), 4293-4304.
89. Barski, A., et al. (2007). High-resolution profiling of histone methylations in the human genome. Cell, 129(4), 823-837.
90. Talasz, H., et al. (2005). Histone H4-lysine 20 monomethylation is increased in promoter and coding regions of active genes and correlates with hyperacetylation. The Journal of Biological Chemistry, 280(46), 38814-38822.
91. Vakoc, C. R., et al. (2006). Profile of histone lysine methylation across transcribed mammalian chromatin. Molecular and Cellular Biology, 26(24), 9185-9195.
92. Loenarz, C., & Schofield, C. J. (2008). Expanding chemical biology of 2-oxoglutarate oxygenases. Nature Chemical Biology, 4(3), 152-156.
93. Bjorkman, M., et al. (2012). Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene, 31(29), 3444-3456.
94. Rose, N. R., et al. (2010). Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. Journal of Medicinal Chemistry, 53(4), 1810-1818.
95. King, O. N., et al. (2010). Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PloS One, 5(11), e15535.
96. Chen, H. Y., et al. (1998). Ubiquitination of histone H3 in elongating spermatids of rat testes. The Journal of Biological Chemistry, 273(21), 13165-13169.
97. Thorne, A. W., et al. (1987). The structure of ubiquitinated histone H2B. The EMBO Journal, 6(4), 1005-1010.
98. Osley, M. A. (2006). Regulation of histone H2A and H2B ubiquitylation. Briefings in Functional Genomics & Proteomics, 5(3), 179-189.
99. Wang, H., et al. (2004). Role of histone H2A ubiquitination in Polycomb silencing. Nature, 431(7010), 873-878.
100. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annual Review of Biochemistry, 70, 503-533.
101. Fierz, B., et al. (2011). Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nature Chemical Biology, 7(2), 113-119.
102. Johnsen, S. A. (2012). The enigmatic role of H2Bub1 in cancer. FEBS Letters, 586(11), 1592-1601.
103. Kim, J., et al. (2009). RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell, 137(3), 459-471.
104. Shema, E., et al. (2008). The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes & Development, 22(19), 2664-2676.
105. Chernikova, S. B., et al. (2010). Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells. Radiation Research, 174(5), 558-565.
106. Hahn, M. A., et al. (2012). The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Human Molecular Genetics, 21(3), 559-568.
107. Prenzel, T., et al. (2011). Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Research, 71(17), 5739-5753.
108. Zhao, Y., et al. (2008). A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Molecular Cell, 29(1), 92-101.
109. Zhang, X. Y., et al. (2008). The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Molecular Cell, 29(1), 102-111.
110. Zhang, Y., et al. (2011). Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. Journal of Cancer Research and Clinical Oncology, 137(8), 1245-1253.
111. Liu, Y. L., et al. (2010). Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer. Journal of Gastroenterology and Hepatology, 25(11), 1800-1805.
112. Davie, J. R., & Murphy, L. C. (1994). Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin. Biochemical and Biophysical Research Communications, 203(1), 344-350.
113. Davie, J. R., & Murphy, L. C. (1990). Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry, 29(20), 4752-4757.
114. Li, B., Carey, M., & Workman, J. L. (2007). The role of chromatin during transcription. Cell, 128(4), 707-719.
115. Belotserkovskaya, R., et al. (2003). FACT facilitates transcription-dependent nucleosome alteration. Science, 301(5636), 1090-1093.
116. Pavri, R., et al. (2006). Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell, 125(4), 703-717.
117. Fuchs, G., et al. (2012). RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Molecular Cell, 46(5), 662-673.
118. Zhang, F., & Yu, X. (2011). WAC, a functional partner of RNF20/40, regulates histone H2B ubiquitination and gene transcription. Molecular Cell, 41(4), 384-397.
119. Shema, E., et al. (2011). RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression. Molecular Cell, 42(4), 477-488.
120. Karpiuk, O., et al. (2012). The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. Molecular Cell, 46(5), 705-713.
121. Shiloh, Y., et al. (2011). RNF20-RNF40: a ubiquitin-driven link between gene expression and the DNA damage response. FEBS Letters, 585(18), 2795-2802.
122. Nakamura, K., et al. (2011). Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. Molecular Cell, 41(5), 515-528.
123. Moyal, L., et al. (2011). Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Molecular Cell, 41(5), 529-542.